Skip to main content
v2026.11,858 entries · CC-BY 4.0
LAC HealthMedical & Research SuppliesReagents, PPE & instruments — chain-of-custody documented.Fast, traceable sourcing built for regulated research environments, from bench consumables to instrumentation.Shop lac.us CodeCASRAIlac.us

cBioPortal: What It Is, Instances, Tabs and How to Cite It

cBioPortal explained: who runs it, the public, GENIE, CCDI and PDX instances, what each Results View tab does, and the three papers to cite.

Written and maintained by CASRAI Editorial Board

Last updated

cBioPortal for Cancer Genomics is an open-access web resource for exploring, visualizing and analyzing multidimensional cancer genomics data. This page is for researchers deciding whether cBioPortal fits their question, which of its several public instances to use, what the Results View tabs do, and how to cite it. The facts below come from the project’s own documentation and the three publications it lists, checked 2026-11-07.

What cBioPortal is

The 2013 Science Signaling paper by Gao and colleagues describes cBioPortal as a web resource for exploring, visualizing and analyzing multidimensional cancer genomics data, covering genetic, epigenetic, gene expression and proteomic events. It supports survival analysis, patient-centric queries and programmatic access, and is designed so that users do not need bioinformatics expertise. The original 2012 Cancer Discovery paper by Cerami and colleagues introduced it as an open-access resource for interactive exploration of such data; at that time it held more than 5,000 tumor samples from 20 cancer studies (a 2012 figure, not a current count).

It is also software. The documentation says the code is available under an open source license via GitHub (github.com/cbioportal/cbioportal), so institutions can run their own instance with their own data.

Who runs it and what it covers

According to the project’s About page, the software is developed and maintained by a multi-institutional team: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Princess Margaret Cancer Centre, Children’s Hospital of Philadelphia, The Hyve, SE4BIO and Bilkent University. The main public site is hosted by the Center for Molecular Oncology at Memorial Sloan Kettering. Funders named on the page include the National Cancer Institute (through the ITCR and HTAN programs), the MSK Kravis Center, Dana-Farber, the American Association for Cancer Research (for Project GENIE), Break Through Cancer and the Gray Foundation.

The data is organized into studies, each contributed by a project or institution. The public portal hosts data from large programs such as The Cancer Genome Atlas (TCGA). Terms of reuse are set per study and source, so check the study’s own description and publication before redistributing or combining data. For a comparison of where TCGA data is distributed from, see Genomic Data Commons (GDC).

Which instance? A map of the cBioPortal family

Because the software is open source, “cBioPortal” can mean several different sites. The instances below are the ones named in the documentation and operated by the project’s partners:

Instance What it is
Public portal (cbioportal.org) Hosted by the MSK Center for Molecular Oncology; the general-purpose site for public cancer genomics studies.
AACR Project GENIE (genie.cbioportal.org) An international registry from 19 cancer centers; the 2023 Cancer Research paper reports more than 130,000 patients with data made public through this site, plus longitudinal BPC data on 25,000 patients (several thousand of them in cBioPortal).
CCDI cBioPortal An instance run for the Childhood Cancer Data Initiative (CCDI) at cbioportal.ccdi.cancer.gov, set up so users can explore and analyze data without downloading or processing large datasets.
PDX portal at The Jackson Laboratory A separate cBioPortal instance at cbioportal.informatics.jax.org, a Jackson Laboratory domain, presented as cBioPortal for patient-derived xenograft (PDX) cancer genomics.

The practical consequence: the instance you used is part of your methods. Record which site, which study identifiers and the date you accessed them.

Using the interface

The user guide is organized by role (portal user, API user, instance maintainer, developer) and documents the interface by page. The terms below are the ones the documentation uses.

  • Study View summarizes a single study, and supports building virtual studies from selected samples.
  • Group Comparison compares defined sets of samples or patients.
  • Query / Results View runs a gene-centric query across one or more studies. The results page is split into tabs.
  • Patient View shows the data for one patient.
  • Onco Query Language (OQL) lets you specify the alterations you want to match for each gene in a query.

Results View tabs

The user guide lists these Results View tabs: OncoPrint, Cancer Types Summary, Mutual Exclusivity, Plots, Mutations, Co-expression, Comparison/Survival, CN Segments, Pathways and Downloads. The guide’s page index links each tab to tutorial slides and a recorded webinar, and the Mutations tab also has a how-to video on filtering and adding clinical data. Survival analysis is one of the capabilities the 2013 paper describes. Work through the tutorial slides for the tab you need rather than relying on a summary here.

For file formats if you plan to load your own data into a self-hosted instance, the documentation has a dedicated File Formats section. Programmatic access is covered under API documentation, and the docs mention a “How to download data” video and an “API and R Client” webinar. The sign-in and account options, where an instance offers them, are on the instance itself.

How to cite cBioPortal

The documentation’s overview page lists three publications. Cite the portal papers and, separately, the paper for each study whose data you analyzed (editorial advice, consistent with how repository citation works generally).

  1. Cerami E, et al. Cancer Discovery. 2012 May;2(5):401-404. doi:10.1158/2159-8290.CD-12-0095. PMID 22588877.
  2. Gao J, et al. Science Signaling. 2013 Apr 2;6(269):pl1. doi:10.1126/scisignal.2004088. PMID 23550210.
  3. de Bruijn I, et al. Cancer Research. 2023 Dec 1;83(23):3861-3867. doi:10.1158/0008-5472.CAN-23-0816. PMID 37668528.

The third paper is the one most relevant when you use GENIE or the longitudinal BPC data.

Strengths and limits

Strengths (as documented). Open access; no bioinformatics expertise needed for common queries; combines several data types in one query; programmatic access and a self-hostable open source codebase; an active multi-institution maintainer group.

Limits (editorial interpretation).

  • It is an exploration and visualization layer, not a substitute for the original data source when you need the full primary data, controlled-access records or a specific data release; for access rules see the NIH Genomic Data Sharing policy.
  • Study contents change as studies are added or updated, so a figure you read today may differ later. Record the date and study identifiers.
  • Reuse terms differ by study; do not assume one license for the whole portal.

Alternatives and related resources

Resource Relationship
Genomic Data Commons A data repository for the underlying NCI genomic data, including TCGA, rather than an exploration portal.
TCGA A major program whose data appears in cBioPortal studies.
Domain repositories in general The category cBioPortal’s data sources belong to; see also data repository.

Frequently asked questions

Is cBioPortal a database?

It is a web portal and open source software layered over study datasets that are loaded into a database. The documentation includes a File Formats section describing how study data is structured for loading.

Where is the cBioPortal code on GitHub?

At https://github.com/cbioportal/cbioportal, the source repository the documentation points to.

Does cBioPortal include TCGA data?

Yes, the public portal hosts data from large programs such as TCGA; see the TCGA entry for what the program is.

How do I cite cBioPortal?

Use the three references in the citation section above, and add the primary publication of each study you analyzed.

Sources

All links checked 2026-11-07.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about cBioPortal: What It Is, Instances, Tabs and How to Cite It

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →